Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$47.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Phillips 66
PSX
|
+$34.7M |
| 4 |
Chevron
CVX
|
+$31.9M |
| 5 |
Johnson Controls International
JCI
|
+$31.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$51.8M |
| 2 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$49.5M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$48.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$37.7M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.69% |
| 2 | Industrials | 11.81% |
| 3 | Healthcare | 11.19% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Replimune Group
REPL
$1.39B
| $436K | 0.01% |
24,667
-7,229
| -23% | -$172K |
|
|
BPMC
1702
DELISTED
Blueprint Medicines
BPMC
| $435K | 0.01% |
+9,663
| New | +$435K |
|
1703
PUT
Etsy
ETSY
$7.99B
| $435K | 0.01% |
3,900
+100
| +3% | +$12.4K |
|
1704
CALL
Stanley Black & Decker
SWK
$14.9B
| $435K | 0.01% |
5,400
-16,900
| -76% | -$1.42M |
|
1705
PUT
Diamondback Energy
FANG
$57.6B
| $434K | 0.01% |
3,200
-1,000
| -24% | -$139K |
|
1706
PUT
Rambus
RMBS
$9.44B
| $434K | 0.01% |
+8,500
| New | +$365K |
|
1707
PUT
Kohl's
KSS
$2.08B
| $433K | 0.01% |
18,400
-2,800
| -13% | -$79K |
|
1708
Cogent Biosciences
COGT
$6.29B
| $432K | 0.01% |
40,073
+5,467
| +16% | +$69.9K |
|
1709
Acushnet Holdings
GOLF
$5.24B
| $431K | 0.01% |
+8,456
| New | +$410K |
|
1710
Mercer International
MERC
$26.9M
| $431K | 0.01% |
44,075
+16,631
| +61% | +$188K |
|
1711
Target
TGT
$77.2B
| $431K | 0.01% |
2,600
-16,337
| -86% | -$2.69M |
|
1712
Community Trust Bancorp
CTBI
$1.39B
| $429K | 0.01% |
11,312
+4,535
| +67% | +$193K |
|
1713
CALL
Corning
GLW
$125B
| $428K | 0.01% |
12,100
+4,000
| +49% | +$139K |
|
1714
Builders FirstSource
BLDR
$7.56B
| $427K | 0.01% |
+4,810
| New | +$381K |
|
1715
Magnite
MGNI
$3.38B
| $427K | 0.01% |
46,134
-143,882
| -76% | -$1.53M |
|
|
AXON
1716
CALL
Axon Enterprise
AXON
$48.5B
| $426K | 0.01% |
1,900
+200
| +12% | +$39.8K |
|
1717
Nicolet Bankshares
NIC
$3.62B
| $426K | 0.01% |
6,755
-4,268
| -39% | -$308K |
|
1718
PUT
Concentrix
CNXC
$1.59B
| $425K | 0.01% |
3,500
-3,200
| -48% | -$435K |
|
1719
Vericel Corp
VCEL
$2.17B
| $424K | 0.01% |
+14,453
| New | +$419K |
|
1720
CALL
Delek US
DK
$4.17B
| $423K | 0.01% |
18,500
+6,100
| +49% | +$153K |
|
1721
PUT
FirstEnergy
FE
$26.9B
| $420K | 0.01% |
10,500
+5,100
| +94% | +$206K |
|
1722
Fluor
FLR
$6.86B
| $417K | 0.01% |
+13,493
| New | +$464K |
|
|
RPT
1723
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $416K | 0.01% |
43,762
-2,321
| -5% | -$23.4K |
|
1724
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $415K | 0.01% |
+4,811
| New | +$415K |
|
1725
MacroGenics
MGNX
$256M
| $415K | 0.01% |
57,936
+26,781
| +86% | +$161K |
|
Similar funds
Paul Tudor Jones's Q1 2023 Portfolio in Review
As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.
- Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
- Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
- Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
- Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
- Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
- Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
- Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.